摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide | 625380-44-1

中文名称
——
中文别名
——
英文名称
N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide
英文别名
N-(6-bromo-8-nitro-2-oxochromen-3-yl)acetamide
N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide化学式
CAS
625380-44-1
化学式
C11H7BrN2O5
mdl
——
分子量
327.091
InChiKey
OEZOEKHVZJTQBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    587.2±50.0 °C(Predicted)
  • 密度:
    1.82±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:0cef062c3638fd29a1fa8f648b3365c1
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide 在 palladium 10% on activated carbon 氢气potassium carbonate 作用下, 以 乙醇 为溶剂, 60.0 ℃ 、400.01 kPa 条件下, 反应 1.0h, 以70%的产率得到3-acetamido-8-aminocoumarin
    参考文献:
    名称:
    Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
    摘要:
    本发明涉及3-氨基-8-(1-哌嗪基)-2H-1-苯并吡喃-2-酮或其药学上可接受的盐或其药学上可接受的盐的水合物的延长释放配方。该发明还涉及这些延长释放配方的制备以及它们在预防或治疗疾病,特别是疼痛和中枢神经系统疾病,如抑郁症、焦虑症和运动障碍中的使用。
    公开号:
    US20060013874A1
  • 作为产物:
    描述:
    5-溴-3-硝基水杨醛N-乙酰甘氨酸 以to yield N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide (3*)的产率得到N-(6-bromo-8-nitro-2-oxo-2H-1-benzopyran-3-yl)acetamide
    参考文献:
    名称:
    1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
    摘要:
    本发明涉及已知的1-[2H-1-苯并吡喃-2-酮-8-基]-哌嗪衍生物的新用途,该衍生物是广谱5-HT受体结合化合物,具有强效的5-HT1A受体激动活性、5-Ht1D受体拮抗活性和5-HT7受体激动活性等多种功能性血清素受体活性。本发明的化合物可用于制备用于治疗、改善或预防运动障碍的药物。本发明涉及一般式(1)中符号具有描述中所给含义的化合物。
    公开号:
    US20050215551A1
点击查看最新优质反应信息

文献信息

  • [EN] 1-[2H-1-BENZOPYRAN-2-ONE-8-YL]-PIPERAZINE DERIVATIVES FOR THE TREATMENT OF PAIN<br/>[FR] ANTI-DOULEUR A BASE DE DERIVES DE 1-[2H-1-BENZOPYRAN-2-ONE-8-YL]-PIPERAZINE
    申请人:SOLVAY PHARM BV
    公开号:WO2005092340A1
    公开(公告)日:2005-10-06
    The invention relates to a novel use of known 1-[2H-1-benzopyran-2-one-8-yl]­-piperazine derivatives, broad spectrum 5-HT receptor binding compounds, having amongst other functional serotonin receptor activities, potent 5-HT1A-agonistic as well as 5-HT1D-antagonistic activity. The compounds of the invention are useful for the preparation of medicaments for treating pain. The invention relates to compounds of the general formula (1) wherein the symbols have the meanings as given in the description.
    这项发明涉及已知的1-[2H-1-苯并吡喃-2-酮-8-基]-哌嗪衍生物的新用途,这些衍生物是广谱5-HT受体结合化合物,除了其他功能性血清素受体活性外,还具有强效的5-HT1A激动作用和5-HT1D拮抗作用。该发明的化合物可用于制备用于治疗疼痛的药物。该发明涉及具有一般式(1)的化合物,其中符号的含义如描述中所给。
  • [EN] 1-[2H-1-BENZOPYRAN-2-ONE-8-YL]-PIPERAZINE DERIVATIVES FOR THE TREATMENT OF MOVEMENT DISORDERS<br/>[FR] DERIVES DE 1-[2H-1-BENZOPYRAN-2-ONE-8-YL]-PIPERAZINE UTILISES DANS LE TRAITEMENT DES TROUBLES DU MOUVEMENT
    申请人:SOLVAY PHARM BV
    公开号:WO2005092339A1
    公开(公告)日:2005-10-06
    The invention relates to a novel use of known 1-[2H-1-benzopyran-2-one-8-yl]­piperazine derivatives, broad spectrum 5-HT receptor binding compounds, having amongst other functional serotonin receptor activities, potent 5-HT1A receptor agonistic activity, 5-HT1D receptor antagonistic activity and 5-HT7 receptor agonistic activity. The compounds of the invention are useful for the preparation of medicaments for treating, ameliorating or preventing movement disorders. The invention relates to compounds of the general formula (1) (1) wherein the symbols have the meanings as given in the description.
    这项发明涉及已知的1-[2H-1-苯并吡喃-2-酮-8-基]哌嗪衍生物的新用途,这些衍生物是广谱5-HT受体结合化合物,除了其他功能性血清素受体活性外,还具有强效的5-HT1A受体激动活性、5-HT1D受体拮抗活性和5-HT7受体激动活性。该发明的化合物可用于制备用于治疗、改善或预防运动障碍的药物。该发明涉及一般式(1)(1)的化合物,其中符号的含义如描述中所示。
  • [EN] PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL) -2H-1-BENZOPYRAN-2-ONE AND SALTS AND HYDRATES THEREOF<br/>[FR] PROCEDE POUR L'ELABORATION DE 3-AMINO-8-(1-PIPERAZINYL)-2H-1-BENZOPYRAN-2-ONE ET DE SES SELS ET HYDRATES
    申请人:SOLVAY PHARM BV
    公开号:WO2005092338A1
    公开(公告)日:2005-10-06
    The invention relates to a novel process for the preparation of 3-amino-8-(1­piperazinyl)-2H-1-benzopyran-2-one, a broad spectrum 5-HT receptor binding ligand having potent 5-HT1A-agonistic as well as 5-HT1D-antagonistic activity. The invention also relates to novel salts and solvates, in particular hydrates of salts of said compound, as well as to their use as medicaments. The invention relates the compounds with the formula (7).
    这项发明涉及一种新型制备3-氨基-8-(1-哌嗪基)-2H-1-苯并吡喃-2-酮的方法,该方法是一种广谱5-HT受体结合配体,具有强效的5-HT1A激动作用和5-HT1D拮抗活性。该发明还涉及新型盐和溶剂合物,特别是该化合物的盐的水合物,以及它们作为药物的用途。该发明涉及具有以下结构式(7)的化合物。
  • 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
    申请人:Bakker Cornelis
    公开号:US20050215551A1
    公开(公告)日:2005-09-29
    The invention relates to a novel use of known 1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives, broad spectrum 5-HT receptor binding compounds, having amongst other functional serotonin receptor activities, potent 5-HT 1A receptor agonistic activity, 5-Ht 1D receptor antagonistic activity and 5-HT 7 receptor agonistic activity. The compounds of the invention are useful for the preparation of medicaments for treating, ameliorating or preventing movement disorders. The invention relates to compounds of the general formula (1) wherein the symbols have the meanings as given in the description.
    本发明涉及已知的1-[2H-1-苯并吡喃-2-酮-8-基]-哌嗪衍生物的新用途,该衍生物是广谱5-HT受体结合化合物,具有强效的5-HT1A受体激动活性、5-Ht1D受体拮抗活性和5-HT7受体激动活性等多种功能性血清素受体活性。本发明的化合物可用于制备用于治疗、改善或预防运动障碍的药物。本发明涉及一般式(1)中符号具有描述中所给含义的化合物。
  • 1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
    申请人:Bakker Cornelis
    公开号:US20050215567A1
    公开(公告)日:2005-09-29
    The invention relates to a novel use of known 1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives, broad spectrum 5-HT receptor binding compounds, having amongst other functional serotonin receptor activities, potent 5-HT 1A -agonistic as well as 5-HT 1D -antagonistic activity. The compounds of the invention are useful for the preparation of medicaments for treating pain. The invention relates to compounds of the general formula (1) wherein the symbols have the meanings as given in the description
    本发明涉及已知的1-[2H-1-苯并吡喃-2-酮-8-基]-哌嗪衍生物的新用途,这些化合物是广谱5-HT受体结合化合物,除了其他功能性的血清素受体活性外,还具有强效的5-HT1A-激动剂和5-HT1D-拮抗活性。本发明的化合物可用于制备用于治疗疼痛的药物。本发明涉及通式(1)中符号具有所述说明中给出的含义的化合物。
查看更多